DK1362040T3 - Fremgangsmåde til fremstilling af mesylater af piperidinderivater - Google Patents

Fremgangsmåde til fremstilling af mesylater af piperidinderivater

Info

Publication number
DK1362040T3
DK1362040T3 DK02719858T DK02719858T DK1362040T3 DK 1362040 T3 DK1362040 T3 DK 1362040T3 DK 02719858 T DK02719858 T DK 02719858T DK 02719858 T DK02719858 T DK 02719858T DK 1362040 T3 DK1362040 T3 DK 1362040T3
Authority
DK
Denmark
Prior art keywords
mesylates
preparing
piperidine derivatives
piperidine
derivatives
Prior art date
Application number
DK02719858T
Other languages
Danish (da)
English (en)
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of DK1362040T3 publication Critical patent/DK1362040T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK02719858T 2001-02-16 2002-02-14 Fremgangsmåde til fremstilling af mesylater af piperidinderivater DK1362040T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (1)

Publication Number Publication Date
DK1362040T3 true DK1362040T3 (da) 2005-01-24

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02719858T DK1362040T3 (da) 2001-02-16 2002-02-14 Fremgangsmåde til fremstilling af mesylater af piperidinderivater

Country Status (35)

Country Link
US (1) US7030241B2 (xx)
EP (1) EP1362040B1 (xx)
JP (1) JP4328528B2 (xx)
KR (2) KR101000733B1 (xx)
CN (1) CN1176079C (xx)
AR (1) AR034206A1 (xx)
AT (1) ATE284875T1 (xx)
AU (1) AU2002250962B2 (xx)
BG (1) BG66101B1 (xx)
BR (1) BR0205683A (xx)
CA (1) CA2422703C (xx)
CZ (1) CZ301780B6 (xx)
DE (1) DE60202261T2 (xx)
DK (1) DK1362040T3 (xx)
DZ (1) DZ3489A1 (xx)
ES (1) ES2230481T3 (xx)
HK (1) HK1059934A1 (xx)
HR (1) HRP20030610B1 (xx)
HU (1) HUP0400772A3 (xx)
IL (1) IL153509A (xx)
IS (1) IS2417B (xx)
ME (1) MEP37508A (xx)
MX (1) MXPA03002359A (xx)
MY (1) MY130687A (xx)
NO (1) NO324460B1 (xx)
NZ (1) NZ524632A (xx)
PL (1) PL208363B1 (xx)
PT (1) PT1362040E (xx)
RS (1) RS51126B (xx)
RU (1) RU2272036C2 (xx)
SI (1) SI1362040T1 (xx)
SK (1) SK286143B6 (xx)
UA (1) UA75390C2 (xx)
WO (1) WO2002066449A2 (xx)
ZA (1) ZA200301590B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
EP2059244A1 (en) 2006-08-31 2009-05-20 Solvay Pharmaceuticals B.V. Titration schedule for bifeprunox for treating schizophrenia and kits for use therein
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
EP2249838A4 (en) 2008-02-05 2012-05-02 Harbor Biosciences Inc PHARMACEUTICAL FORMS IN SOLID STATE
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32935A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Polimorfos de pardoprunox

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
EP0185429A1 (en) * 1984-12-21 1986-06-25 Duphar International Research B.V New bicyclic heteroaryl piperazines
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
DE69736704T2 (de) * 1996-03-29 2007-09-13 Duphar International Research B.V. Piperazin- und piperidin- derivate
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
NO324460B1 (no) 2007-10-22
BR0205683A (pt) 2004-07-06
HUP0400772A3 (en) 2008-02-28
KR20030077523A (ko) 2003-10-01
US7030241B2 (en) 2006-04-18
WO2002066449A2 (en) 2002-08-29
NO20031754D0 (no) 2003-04-15
WO2002066449A3 (en) 2002-10-24
UA75390C2 (en) 2006-04-17
SK3092003A3 (en) 2003-09-11
ES2230481T3 (es) 2005-05-01
CA2422703A1 (en) 2002-08-29
SK286143B6 (sk) 2008-04-07
JP2004518741A (ja) 2004-06-24
YU64403A (sh) 2006-05-25
IS6876A (is) 2003-07-17
NZ524632A (en) 2004-03-26
HRP20030610B1 (en) 2006-02-28
AU2002250962B2 (en) 2006-08-24
IS2417B (is) 2008-10-15
IL153509A (en) 2007-12-03
KR20080064206A (ko) 2008-07-08
PL369330A1 (en) 2005-04-18
CN1176079C (zh) 2004-11-17
CZ2003697A3 (cs) 2003-06-18
PL208363B1 (pl) 2011-04-29
ZA200301590B (en) 2004-02-05
RU2272036C2 (ru) 2006-03-20
CZ301780B6 (cs) 2010-06-23
SI1362040T1 (en) 2005-06-30
MY130687A (en) 2007-07-31
BG108090A (bg) 2004-12-30
US20040077631A1 (en) 2004-04-22
MEP37508A (en) 2011-02-10
JP4328528B2 (ja) 2009-09-09
HRP20030610A2 (en) 2005-06-30
RS51126B (sr) 2010-10-31
PT1362040E (pt) 2005-05-31
DZ3489A1 (fr) 2002-08-29
MXPA03002359A (es) 2003-06-30
CA2422703C (en) 2010-04-13
HK1059934A1 (en) 2004-07-23
EP1362040B1 (en) 2004-12-15
CN1463268A (zh) 2003-12-24
DE60202261D1 (de) 2005-01-20
IL153509A0 (en) 2003-07-06
KR101000733B1 (ko) 2010-12-14
DE60202261T2 (de) 2005-05-19
NO20031754L (no) 2003-04-15
AR034206A1 (es) 2004-02-04
BG66101B1 (bg) 2011-04-29
ATE284875T1 (de) 2005-01-15
KR100859106B1 (ko) 2008-09-18
EP1362040A2 (en) 2003-11-19
HUP0400772A2 (hu) 2004-08-30

Similar Documents

Publication Publication Date Title
DK1303478T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1277722T3 (da) Fremgangsmåde til fremstilling af methanol
DK1370150T3 (da) t-trinsproces til fremstilling af tyggegummi
DK1312406T3 (da) Fremgangsmåde til rensning af syntesegas
DK1293507T3 (da) Fremgangsmåde til fremstilling af krystaller
DK1296935T3 (da) Fremgangsmåde til fremstilling af substituerede octanoylamider
DK1223474T3 (da) Fremgangsmåde til fremstilling af estervoks
DK1412459T3 (da) Fremgangsmåde til fremstilling af mellemdestillater
DK1182261T3 (da) Fremgangsmåde til frembringelse af basisk aminosyre
DK1253153T3 (da) Fremgangsmåde til fremstilling af 4"-substituerede-9-deoxo-9a-aza-9a-homoerythromycin-A-derivater
DK1296656T3 (da) Fremgangsmåde til fremstilling af et præparat
DK2135957T3 (da) Fremgangsmåde til fremstilling af glucaner
DK1180544T3 (da) Fremgangsmåde til fremstilling af syntesegas
DK1362040T3 (da) Fremgangsmåde til fremstilling af mesylater af piperidinderivater
DK1147075T3 (da) Fremgangsmåde til fremstilling af L-phenylephrinhydrochlorid
DK1667967T3 (da) Fremgangsmåde til fremstilling af 2-oxo-1-pyrrolidin-derivater
DK1353923T3 (da) Forbedret fremgangsmåde til syntese af carbapenem
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
DK1575941T3 (da) Fremgangsmåde til fremstilling af (S)-pantoprazol
DK1401816T3 (da) Fremgangsmåde til fremstilling af piperidinderivatet fexofenadin
DK1326836T3 (da) Fremgangsmåde til fremstilling af 3-amino-2-chlor-4-methylpyridin
DK1456229T3 (da) Fremgangsmåe til fremstilling af echinocandin-derivater
DK1446107T3 (da) Fremgangsmåde til fremstilling af tabletter omfattende s-adenosylmethionin
DK1395587T3 (da) Fremgangsmåde til fremstilling af imipenem
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater